Work

CK2 Inhibitor CX4945 Shows Strong In Vivo Synergistic Anti-Leukemia Activity with Rapamycin in B-ALL Due to Enhanced Ikaros Mediated Repression of mTOR Pathway

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-131790

Authors: Chandrika Gowda, Chunhua Song, Yali Ding, Pavan kumar Dhanyamraju, Soumya Iyer, Jonathon Payne, Yevgeniya Bamme, Arati Sharma, Kimberly J. Payne, Sinisa Dovat

Institutions: Penn State Milton S. Hershey Medical Center, Pennsylvania State University, Loma Linda University

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2986090507

Cites:

Cited by: 1

Related to: 10